The 2023 data showcase Germany as the leader with an R&D budget of 10.08 Billion USD in Health and Medical Sciences. France and Japan followed, although Japan had the highest growth in 2023 at 19.68%, while other countries like Iceland and Norway also showed substantial increases. Conversely, nations like Romania and Lithuania saw declines. The past 5-year CAGR trend and year-on-year changes suggest strong investments, especially in Europe and Asia, barring a few exceptions.
Future trends indicate that countries with emerging economies may increasingly prioritize R&D investment in health and medical sciences to enhance local innovation capabilities, influenced by rapid technological advancement and healthcare needs expansion.
Top countries in R&D Budget for Health and Medical Sciences by Country
| # | 10 Countries | Million US Dollars PPP | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 10,080 | 2023 | +5.08% | +8.08% | View data |
| 2 | 2 France | 4,780 | 2023 | -5.04% | +9.61% | View data |
| 3 | 3 Japan | 4,760 | 2023 | +5.93% | +19.68% | View data |
| 4 | 4 Netherlands | 2,950 | 2023 | +6.67% | +9.84% | View data |
| 5 | 5 Spain | 2,670 | 2023 | +2.17% | +5.57% | View data |
| 6 | 6 Italy | 2,580 | 2023 | +0.4% | +13.95% | View data |
| 7 | 7 Taiwan | 2,460 | 2023 | +3.14% | +7.13% | View data |
| 8 | 8 Australia | 1,460 | 2023 | +4.23% | +9.43% | View data |
| 9 | 9 Sweden | 1,200 | 2023 | +1.5% | +1.27% | View data |
| 10 | 10 Norway | 1,170 | 2023 | +14.67% | +15.38% | View data |
